Pharmaceutical Executive June 5, 2020
Michael J. Hennessey Jr., President and CEO of MJH Life Sciences, the parent company of Pharmaceutical Executive, convened a closed roundtable of pharmaceutical CEOs in mid-May to discuss the industry’s pandemic response and preparations for an as-now uncertain future. The virtual roundtable was moderated by Scott Gottlieb, MD, former FDA commissioner and, more recently, the go-to, non-partisan expert on COVID-19 developments and CNBC Contributor on the topic. Gottlieb received kudos from all the participating leaders as the voice of science and reason, providing the public balanced insights as the pandemic unfolds. Overall, the gathered leaders, representing various therapeutic areas, revenue-sized companies and states of commercialization, are optimistic and predict the industry will rise to the myriad pandemic challenges, ultimately transforming...